Hjem › Multipelt myelom › South Carolina
Kliniske studier for Multipelt myelom i South Carolina
9 studier for Multipelt myelom søker deltakere på steder i South Carolina.
Byer i South Carolina
Offisiell studietekst (engelsk)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Bon Secours Saint Francis Cancer Center, Greenville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07518186A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- MUSC-Hollings Cancer Center, Charleston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- SC Cancer Specialists at St. Joseph's/Candler Bluffton, Bluffton
- St. Joseph's/Candler Smith, Bluffton
- Summit Cancer Care at St. Josph's/Candler Bluffton, Bluffton
- og 1 flere
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Ralph H Johnson VA Medical Center, Charleston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04566328A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Medical University of South Carolina (MUSC) - Hollings Cancer Center, Charleston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05651932Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Cancer Institute - Easley, Easley
- Prisma Health Cancer Institute - Butternut, Greenville
- og 4 flere
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT05561387Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Medical University of South Carolina (MUSC), Charleston
- Gibbs Cancer Center, Spartanburg
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT05243797A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Medical University of South Carolina, Charleston
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 24. mar. 2026 · NCT04988555cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.